z-logo
open-access-imgOpen Access
Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
Author(s) -
Andrew E. Moran,
Michelle C. Odden,
Anusorn Thanataveerat,
Keane Y. Tzong,
Petra W. Rasmussen,
David Guzman,
Lawrence Williams,
Kirsten BibbinsDomingo,
Pamela G. Coxson,
Lee Goldman
Publication year - 2015
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmsa1406751
Subject(s) - medicine , intensive care medicine , medline , political science , law
On the basis of the 2014 guidelines for hypertension therapy in the United States, many eligible adults remain untreated. We projected the cost-effectiveness of treating hypertension in U.S. adults according to the 2014 guidelines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom